20.12.2016 15:00:00

BioLargo, Inc. Discusses Recent Developments, Goals and Milestones for First Half of 2017 in New SNNLive Video Interview on StockNewsNow.com

LOS ANGELES, Dec. 20, 2016 /PRNewswire/ -- StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Dennis Calvert, President & CEO of BioLargo, Inc. (OTCQB: BLGO). The company is developing sustainable technology-based products that can potentially help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy, according to the Company's website (see here: www.BioLargo.com). The video interview was recorded on Thursday, December 8th, 2016 at the LD Micro "Main Event" 2016 in Bel Air, CA.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

Update with BioLargo, Inc. – Discusses Recent Developments, Goals and Milestones for First Half of 2017

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) is developing sustainable technology-based products that can potentially help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter System -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.

Company description and for more information about BioLargo, Inc., please visit: www.BioLargo.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biolargo-inc-discusses-recent-developments-goals-and-milestones-for-first-half-of-2017-in-new-snnlive-video-interview-on-stocknewsnowcom-300381788.html

SOURCE StockNewsNow.com

Nachrichten zu Biolargo Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Biolargo Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biolargo Inc 0,18 -2,21% Biolargo Inc